Asian Annals Click here to go to Medistim website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prasongsukarn, K.
Right arrow Articles by Lichtenstein, S. V
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prasongsukarn, K.
Right arrow Articles by Lichtenstein, S. V
Asian Cardiovasc Thorac Ann 2007;15:127-133
© 2007 Asia Publishing EXchange Ltd


ORIGINAL CONTRIBUTIONS

Aortic and Mitral Prosthetic Valve Replacement in Age Groups 61–65 & 66–70 Years

Kriengchai Prasongsukarn, MD, WR Eric Jamieson, MD, Eva Germann, MSc, Florence Chan, Samuel V Lichtenstein, MD

University of British Columbia, Vancouver, Canada

For reprint information contact: WR Eric Jamieson, MD Tel: 1 604 806 8383 Fax: 1 604 806 8384 Email: wrej{at}interchange.ubc.ca, 486 Burrard Bldg, St. Paul’s Hospital, 1081 Burrard Street, Vancouver, Canada V6Z 1Y6.

Prosthesis choice for aortic and mitral valve replacements in patients aged 61–70 years is difficult. We evaluated prostheses in age groups 61–65 and 66–70 years. Freedom from major thromboembolism and hemorrhage was greater for bioprostheses than mechanical prostheses in both age groups after aortic valve replacement, but only in the younger age group after mitral valve replacement. Freedom from valve-related re-operation was greater after mitral valve replacement with mechanical prostheses in both age groups, but no difference after aortic valve replacement. Valve type was predictive of major thromboembolism and hemorrhage, except in older patients undergoing mitral valve replacement. Bioprostheses are favored for aortic valve replacement in both age groups, but the risk of re-operation with a bioprosthesis in the mitral position in patients aged 61–65 years favors a mechanical prosthesis. Prosthesis choice is less definite in those aged 66–70 years.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by the Asia Publishing EXchange Ltd.